|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.09 USD | -3.90% |
|
-4.90% | +1.31% |
| Capitalization | 1.34B 1.14B 1.05B 985M 1.84B 123B 1.95B 12.04B 4.78B 57.99B 5.01B 4.91B 211B | P/E ratio 2025 * |
15.9x | P/E ratio 2026 * | 11x |
|---|---|---|---|---|---|
| Enterprise value | 3.1B 2.63B 2.44B 2.28B 4.25B 284B 4.51B 27.89B 11.07B 134B 11.61B 11.37B 489B | EV / Sales 2025 * |
0.96x | EV / Sales 2026 * | 0.92x |
| Free-Float |
75.16% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: AdaptHealth Corp.
| 1 day | -3.90% | ||
| 1 week | -4.90% | ||
| Current month | +1.31% | ||
| 1 month | -0.20% | ||
| 3 months | +9.32% | ||
| 6 months | +4.67% | ||
| Current year | +1.31% |
| 1 week | 9.88 |  | 10.87 |
| 1 month | 9.53 | | 10.92 |
| Current year | 9.53 | | 10.92 |
| 1 year | 7.1 | | 11.63 |
| 3 years | 6.37 | | 22.94 |
| 5 years | 6.37 | | 41.58 |
| 10 years | 6.37 | | 41.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Suzanne Foster
CEO | Chief Executive Officer | 56 | 20/05/2024 |
Jason Clemens
DFI | Director of Finance/CFO | 48 | 03/08/2020 |
Toby Barnhart
COO | Chief Operating Officer | 58 | 23/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Terence Connors
BRD | Director/Board Member | 71 | 01/07/2017 |
Susan Weaver
BRD | Director/Board Member | 65 | 01/02/2018 |
Dale Wolf
CHM | Chairman | 72 | 01/07/2024 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.90% | -4.90% | -1.66% | -52.85% | 1.34B | |
| -1.10% | -11.78% | -12.82% | -5.78% | 187B | |
| -0.45% | +4.26% | +13.03% | +22.47% | 129B | |
| +0.29% | -0.39% | +42.57% | +118.58% | 68.76B | |
| -2.06% | -2.57% | -16.09% | -19.15% | 57.49B | |
| +1.35% | +0.45% | +18.55% | +85.96% | 54.56B | |
| +0.09% | +4.26% | - | - | 38.28B | |
| -1.43% | +4.77% | -16.92% | -31.52% | 28.42B | |
| -0.53% | -3.40% | +19.48% | +25.46% | 25.47B | |
| -1.72% | -3.42% | -0.39% | -34.77% | 23.57B | |
| Average | -0.95% | -1.21% | +5.08% | +12.04% | 61.4B | |
| Weighted average by Cap. | -0.63% | -2.70% | +4.01% | +21.59% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.23B 2.75B 2.55B 2.38B 4.44B 297B 4.7B 29.11B 11.56B 140B 12.12B 11.87B 510B | 3.44B 2.93B 2.71B 2.53B 4.72B 316B 5.01B 31B 12.31B 149B 12.9B 12.64B 543B |
| Net income | 88.56M 75.32M 69.81M 65.24M 122M 8.14B 129M 798M 317M 3.84B 332M 325M 13.97B | 131M 111M 103M 96.25M 179M 12B 190M 1.18B 467M 5.67B 490M 480M 20.62B |
| Net Debt | 1.76B 1.5B 1.39B 1.3B 2.42B 162B 2.56B 15.85B 6.29B 76.31B 6.6B 6.46B 278B | 1.82B 1.55B 1.43B 1.34B 2.5B 167B 2.65B 16.38B 6.5B 78.89B 6.82B 6.68B 287B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 10.09 $ | -3.90% | 713,600 |
| 22/01/26 | 10.50 $ | -0.19% | 1,004,648 |
| 21/01/26 | 10.52 $ | +1.15% | 858,600 |
| 20/01/26 | 10.40 $ | -1.98% | 832,411 |
| 16/01/26 | 10.61 $ | -0.28% | 779,184 |
Delayed Quote Nasdaq, January 24, 2026 at 12:00 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AHCO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition